Mark Szczepaniak
Analyst · JMP Securities. Please go ahead
Thanks Chris, and hi everybody. On Page 4, we take a look at the reconciliation between our GAAP income for the quarter and book income or GAAP income was $3.4 million. But on a core basis, the core income was $6.7 million. And Chris alluded to the $3.3 million delta there which related to the debt refinancing, we did refinance our corporate debt in Q1 and we paid off the existing, the older corporate debt. We paid off the existing corporate debt, we had some deferred deal costs, write-offs and some prepayment fees as a result of paying off that debt. And that resulted in about $4.5 million of write-offs pre-tax or that $3.3 million that you're seeing a net effect of adjusting the GAAP income to the core income. So on a core basis $6.7 million. To the right there, you just see the roll-forward of the book value of equity per share from $12.31 to $3.31. And as Chris mentioned $10.93 to $11.12 kind of a key point there, as you see the $11.12 includes that $0.17 write-off, that's the one-time write-off that we talked about refinancing the debt. So really, without having that debt refinanced during the quarter, just based on operations, you could add the $0.17 back to the $11.12. And you really was at $11.29, just based on operational basis. And as Chris mentioned, we are working on coming up with a more economic value of equity per share kind of go along with the book to show the inherent gains and value embedded in the business. On Slide 5, production. Production has increased significantly from Q4 to Q1 30% increase going from $179 million in UPB in Q4 $233 million. As Chris had mentioned, the $233 million is very comparable to the first quarter of 2020 pre-COVID. And that $248 million remember the $248 million had our short-term loan product in there Q1 of ‘21 to $233 million is all of our just our 30-year long-term product. There's no short-term product in there. That's a very strong quarter and not offering a short-term product. Now in April, we did go out and announce to all the brokers that we are now offering our ARV Pro short-term product that we had offered pre-COVID as well as a new short-term product called our Flex interest only product. So we are now taking applications and back to offering our short-term product. On Page 6, the loan portfolio. Loan portfolio ended the quarter just shy of $2 billion $1.99 billion and the $1.99 billion that included selling $57 million worth of UPB during Q1. So absent that sale the portfolio would have been over $2 billion, but $1.99 billion ending the quarter. And the other positive to note there is comparing this first quarter of 2020 to first quarter of ‘21 year-over-year our one to four rental property portfolio has really grown. We've gone from about 40% of our total portfolio being the one to four family property to now at the end of Q1, ‘21 closer to 49%. So we've seen strong demand, investor demand on these one to four residential properties. And you'll see the loan portfolio waterfall in the bottom right of that slide are showing the growth from the $1.94 billion at the end of the year to the $1.99 billion at the end of 3/31 you can see that $57 million UPB loan sale in that report. Page 7, Chris mentioned NPL non-performing loan resolutions have remained strong and consistent. In total, we resolved $49 million worth of UPB in the quarter for a total of $1.3 million gain over and above its contractual principal interest or about 2.7% gain for the quarter. What we've done now starting with Q1 of this year is we've taken those NPL resolutions and we've broken them out into two separate tables. So the top table represents our normal long-term 30-year product and that's the bulk of our portfolio. And it's the 30-year product for loans that did not receive COVID forbearance during 2020 and will give you that in just a minute. The bottom table is our short-term loans, as well as any of the long-term loans that did receive a COVID forbearance. The reason we felt that starting this year, it's appropriate to split out if we wanted to provide more transparency and more information to the investors on the different types of products and characteristics will resolve the loans. Our long-term 30-year loan, when those loans pay-off when resolution is a full pay-off, that we received default interest and prepayment fees. So that makes up the gain. You can see in the top table by just comparing the long-term loans, it's $29 million resolution compared to fourth quarter of 30 and a 3.2 gains compared to 3.5. So that's kind of an apples-to-apples comparison. And what we're seeing now in Q1, apart from a couple things, one, we're now -- the short-term loan resolutions, we didn't show those separately in 2020 because for most of 2020, the short-term loans were held-for-sale, they were part of our health investment portfolio. It wasn’t till towards the end of Q3 that we moved them over to health investments, and now, our special sourcing team is tracking them and they're getting involved in the resolutions. Prior to that, when we were selling the loans, once we sell them, we don't charge them, we don't do any of the resolutions. So now that we have those loans to help investment and it's our intent going forward with opening up the short-term product going forward that we're going to put it in health for investment starting this quarter or first quarter of this year, we're tracking those loans. In the short-term loans, the reason we're bringing them out separate, they do not have prepayment fees. So they have default interest if they pay-off or pay current and they are not performing, but they don't have prepayment fees. So their gains would be expected to be a little bit less, because there's no prepayment fees associated with the short-term product. And then also in that bottom table are the longer-term loans, the 30-year product that did receive COVID forbearances. That's kind of something new for the first quarter, because the loans that did get forbearances during 2020, by the time they receive the forbearance, a majority of those loans were modified or brought current. By the time all that happened, it was going into, say, Q3. Then if the borrowers led non-performing coming out of that forbearance, so there is another 90 days and they went non-performing that brought it right to year-end. So we're first starting to see the resolutions coming through on those loans in Q1. And again, because their loans that went into COVID forbearance, more often than not if the borrower wants to pay-off the loan, you probably would waive the prepayment fees, it's a case-by-case basis, but because we gave them COVID forbearance, we're more likely to waive it. So we felt that's a different characteristic than the long-term loans without prepayment fees. That's why the tables are split. We're hoping that it gives investors, analysts, more information in detail about the different characteristics of our products, as we monitor these non-performing loan resolutions. On Page 8, Chris kind of mentioned our net interest margin end of the quarter at 410 basis points compared to 407 for Q4, and it’s like 418 basis points all the way back to Q1 of 2020. Again a very positive there as even during a tumultuous 2020 with COVID and the suspension of loan production for over six months, we've maintained a very constant margin of over north of 400 basis points. And we've talked before about our locked in spread and our in place portfolio generating a locked in spread. And I think that was very, very strongly demonstrated during a pretty rough year, last year, and this maintained at 400 bps or higher throughout the entire year. Though the right hand side shows our portfolio yield and the cost of funds that kind of comprise the 400 basis points of net margin, the yield has remained strong at 841 at the end of the quarter. As Chris mentioned, our yield is pretty much on top of a whack, which is a positive, obviously, the whack, we have non-performing loans to take away from the whack. As Chris mentioned, our strong resolutions, default interest and prepayment fees is pretty much offsetting the loss of interest income from the non-performing loans to keep that whack in check. And on the cost of funds. Again, very consistent, just 4-basis point change from end of the year to Q1. And a slight uptick for Q1 is as Chris mentioned some of these new warehouse lines that we put in place in Q1. We were just first ramping those up in the quarter and they do have fixed fees. So we have the same fee for the quarter, but you don't have the full balance of a loan on there for the quarter. So that just kind of results in a little bit of a tick up in the cost of funds, as we now get more and more loans on those warehouse lines and fully utilize the lines, those costs will be absorbed into the higher average balance. Slide 9. The loan investment portfolio of performance, we talked about non-accruals have stayed pretty moderate, consistent from Q4 to Q1, it actually went down slightly by 40 basis points in terms of non-performing rates and 17.2 to 16.8. As Chris mentioned, it will take some time to start working off all those non-performing loans, but the key takeaway is as we are working off the non-performing, we're maintaining that close to 3 -- 4.3% gain on all the resolutions. So still strong resolutions as a result is resolving those. On Slide 10 is our CECL reserve. CECL reserve at the end of Q1 was around $5.9 million, which is where we ended the year. So the CECL reserve, the loan loss reserve is flat. We ran multiple different models under COVID stress scenario, just like we did at the end of the year. I know you've heard about some companies saying they're backing off some reserve, [indiscernible] some reserves. We just thought we're growing our portfolio again, adding a lot more loans on the line. We've got more warehouse lines in place to be able to fund the higher originations coming in. And yes, COVID vaccines are out there, people are getting them. It's just a little soon to tell what the impact of that will be long-term. So, I guess, I say it's a cautious optimism that we're watching the economy in the market as everything starts to reopen and we're just kind of holding that reserve steady for now until we get another quarter or two under the belt and see where things go. And at the bottom right of that slide, as Chris mentioned, our charge-offs remain very, very low, and even for Q4, it was only 37 basis points on an annualized basis, based on the charge-offs of Q1, it's 8 basis points on an annualized basis. So our charge-offs remain low. And part of the reason for that is we just said those resolutions remains high. In Q1, 94% of all the resolutions in Q1 and [indiscernible] resolutions in Q1 were loans that paid off or paid current at an overall 2.7% gain. So that's one of the reasons the charge-offs are also so low, the strong resolutions. Chris, with that, I'll turn it back to you.